TAFLUPROST 0.0015% EYE DROP

tafluprost opthalmic
$2.8176per EA

Strength

.0045 mg/.3mL

Manufacturer

Micro Labs Limited

NDC

42571026473

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

4/22/2026

Active Ingredients

TAFLUPROST

Approval Type

Generic (ANDA)

FDA Application

ANDA209051

On Market Since

11/18/2022

Pharmacological Classes

Increased Prostaglandin Activity
Prostaglandin Analog
Prostaglandin Receptor Agonists
Prostaglandins

Price History

1W

0.0%

1M

-4.8%

3M

-7.0%

6M

-1.5%

1Y

-21.5%

3Y

-32.0%

5Y

N/A

All

-34.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.